Erlonat 150mg Tablet (Erlotinib)

Description

Erlonat (Erlotinib) – Drug Information

Generic Name: Erlotinib
Brand Name: Erlonat
Drug Class: Tyrosine Kinase Inhibitor (TKI) / Anti-cancer medication

Description

Erlonat contains erlotinib, a targeted anti-cancer medicine used primarily for the treatment of advanced or metastatic Non-Small Cell Lung Cancer and Pancreatic Cancer. It works by blocking the Epidermal Growth Factor Receptor (EGFR), a protein that promotes the growth and spread of cancer cells.

Indications

• Advanced or metastatic EGFR-positive non-small cell lung cancer (NSCLC)
• Advanced pancreatic cancer, often in combination with chemotherapy (such as gemcitabine)

Mechanism of Action

Erlotinib inhibits EGFR tyrosine kinase activity, preventing cancer cells from receiving signals needed for growth and division. This helps slow or stop tumor progression.

Dosage and Administration

• Take exactly as prescribed by an oncologist.
• Usually administered once daily.
• Should be taken on an empty stomach, at least 1 hour before or 2 hours after meals.
• Swallow the tablet whole with water; do not crush or chew.

Common Side Effects

• Skin rash
• Diarrhea
• Nausea and vomiting
• Fatigue
• Loss of appetite
• Weight loss
• Mouth sores (stomatitis)
• Abdominal pain
• Cough and shortness of breath

Serious Adverse Effects

Seek immediate medical attention if any of the following occur:

• Severe or persistent diarrhea
• Difficulty breathing or worsening cough
• Severe skin reactions
• Eye pain, redness, or vision changes
• Signs of liver problems (yellowing of skin or eyes, dark urine)

Precautions

• Avoid use during pregnancy and breastfeeding.
• Use effective contraception during treatment.
• Avoid smoking, as it may reduce the effectiveness of erlotinib.
• Protect skin from excessive sunlight exposure.
• Inform your doctor about all medications you are taking, especially antacids and acid-reducing medicines, which can interfere with absorption.

Storage

Store below 30°C in a dry place, away from direct sunlight and out of reach of children.